Jan 4, 2018
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies...Dec 23, 2017
Article and Study Summary Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Published in: Lancet...Dec 12, 2017
When: December 12, 2017 @ 9:00AM (2:00 p.m. Abidjan; 4:00 p.m. Johannesburg; 5:00 p.m. Nairobi; 8:00 p.m. Almaty; 8:30 p.m. Yangon) Presented by: Yael Hirsch-Moverman, PhD, MPH ICAP at Columbia...Nov 21, 2017
When: November 21, 2017 @ 9:00AM (2:00 p.m. Abidjan; 4:00 p.m. Johannesburg; 5:00 p.m. Nairobi; 8:00 p.m. Almaty; 8:30 p.m. Yangon) Presented by: Nandita S. Sugandhi, MD Elaine J. Abrams, MD ICAP at Columbia...Nov 2, 2017
Article and Study Summary Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial Published in: Lancet HIV. 2017 Oct 3. DOI: http://dx.doi.org/10.1016/S2352-3018(17)30156-X Authors: Bekker...Join our mailing list to receive the latest news and updates from our team.